Universal-Beteiligungs- und Servicegesellschaft’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Sell
87,551
-10,115
-10% -$139K ﹤0.01% 1405
2026
Q1
$1.21M Sell
97,666
-1,398
-1% -$18.8K ﹤0.01% 1443
2025
Q4
$1.25M Buy
99,064
+21,507
+28% +$246K ﹤0.01% 1420
2025
Q3
$776K Buy
77,557
+289
+0.4% +$2.59K ﹤0.01% 1626
2025
Q2
$625K Buy
77,268
+32,678
+73% +$246K ﹤0.01% 1625
2025
Q1
$374K Buy
+44,590
New +$372K ﹤0.01% 1729

Other funds holding AMRX

Universal-Beteiligungs- und Servicegesellschaft's AMRX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Amneal Pharmaceuticals (AMRX) stake by 10% in Q2 2026, selling an estimated $139K and leaving 87,551 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1405.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in AMRX in Q1 2025 and has held it in 6 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 87,551 shares of Amneal Pharmaceuticals worth $1.52M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 10,115 Amneal Pharmaceuticals shares in Q2 2026, an estimated $139K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1405 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Amneal Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.